"Im Einzelnen bieten wir Ihnen in unserer Geburtshilfe und Perinatalmedizin eine individualisierte Betreuung sowohl vor, während als auch nach der Schwangerschaft. Im gynäkologischen Schwerpunkt werden die Erkrankungen des weiblichen urogenitalen Systems nach den neuesten Erkenntnissen behandelt. Besonderer Schwerpunkt liegt dabei in der Behandlung der Harninkontinenz. Unsere Gynäkologische Onkologie ermöglicht Ihnen eine hoch spezialisierte und nach aktuell wissenschaftlichen Erkenntnissen ausgerichtete Diagnostik und Behandlung bösartiger Erkrankungen. Im zertifizierten Interdisziplinären Brustzentrum werden gut- und bösartige Erkrankungen der Brust diagnostiziert und behandelt."

During the past decade, Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" are "Ovarian Cancer" (5 trials), "Breast Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "Peritoneal Neoplasms" (2 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" are "Drug" (5 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum" are 5 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Greifswald; Klinik für Frauenheilkunde und Brustzentrum, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".